Clinical Trial Update: Study of SGN1 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating SGN1 in patients with advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SGN1

Snippet

Sponsor: Guangzhou Sinogen Pharmaceutical Co., Ltd | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING